Search

Displaying results 8021 - 8030 of 10000 in total
  1. Drug

    VH4367310

    go.drugbank.com/drugs/DB33961
    Experimental

    VH4367310 is under investigation in clinical trial NCT07818915 (A Study to Investigate Pharmacokinetics (PK), Safety, and Tolerability of VH4367310 in Healthy Adult Participants).

  2. Drug

    Urolithin A

    go.drugbank.com/drugs/DB15464
    Experimental

    It has been demonstrated to stimulate mitophagy and improve muscle health in old animals and in preclinical models of aging.[A179494]

  3. Drug

    Aetiocholanolone

    go.drugbank.com/drugs/DB02854
    Experimental

    Etiocholanolone is a major metabolite of testosterone and androstenedione in many mammalian species including humans. It is excreted in the urine. [PubChem]

  4. Drug

    Dolcanatide

    go.drugbank.com/drugs/DB13112
    Investigational

    Dolcanatide has been investigated in Exposure.

  5. Drug

    Nequinate

    go.drugbank.com/drugs/DB11433
    ExperimentalVet approved

    These are compounds containing an hydrogenated quinoline bearing a ketone group. … Nequinate is an antiprotozoan used as a coccidiostat for poultry and rabbits. Nequinate belongs to the family of Hydroquinolones.

  6. Drug

    Bemegride

    go.drugbank.com/drugs/DB13740
    Experimental

    Bemegride is a CNS stimulant that is used to induce convulsions in experimental animals. It has also been used as a respiratory stimulant and in the treatment of barbiturate overdose.

  7. Drug

    Lorecivivint

    go.drugbank.com/drugs/DB14883
    Investigational

    Lorecivivint is under investigation in clinical trial NCT03246399 (A Study of the Safety, Tolerability, and Pharmacokinetics of SM04690 Injectable Suspension Following Single Intradiscal Injection in Subjects

  8. Drug

    Teprasiran

    go.drugbank.com/drugs/DB15064
    Investigational

    Teprasiran is under investigation in clinical trial NCT03510897 (QPI-1002 Phase 3 for Prevention of Major Adverse Kidney Events (MAKE) in Subjects at High Risk for AKI Following Cardiac Surgery).

  9. Drug

    Elezanumab

    go.drugbank.com/drugs/DB15240
    Investigational

    Elezanumab is under investigation in clinical trial NCT03737812 (A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Progressive Forms of Multiple Sclerosis).

  10. Drug

    Afabicin

    go.drugbank.com/drugs/DB15268
    Investigational

    Afabicin is under investigation in clinical trial NCT03723551 (Study to Assess Safety, Tolerability and Efficacy of Afabicin in The Treatment of Participants With Bone or Joint Infection Due to Staphylococcus